Inactive Instrument
Tobira Therapeutics Inc Stock
Stocks
US88883P1012
Biotechnology & Medical Research
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Michael
CEO | Chief Executive Officer | 55 | - |
Scott Reents
DFI | Director of Finance/CFO | 59 | - |
| Corporate Secretary | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.90% | +11.59% | +62.29% | +102.60% | 71.56B | |
| -3.21% | -3.13% | +32.57% | +60.59% | 54.43B | |
| -2.05% | -5.61% | -3.14% | +454.89% | 27.59B | |
| -1.27% | +9.09% | +46.56% | +4.13% | 23.91B | |
| +1.05% | -0.62% | -17.40% | -13.36% | 23.14B | |
| +0.10% | +7.99% | +41.01% | -20.48% | 18.65B | |
| +3.81% | +16.28% | +270.78% | +488.06% | 18.64B | |
| -0.95% | +2.46% | +24.40% | +574.22% | 16.01B | |
| +1.24% | -5.23% | +33.19% | +138.21% | 12.54B | |
| Average | -0.47% | +2.96% | +54.47% | +198.76% | 29.61B | |
| Weighted average by Cap. | -1.22% | +1.72% | +50.57% | +159.95% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
